After losing both his father and uncle to ALS, Target ALS founder Dan Doctoroff, who now lives with ALS himself, set out to break down barriers, accelerate discovery, and build a future where everyone lives.
Dan's unshakeable vision and drive led to Target ALS.
Today, Target ALS has changed the trajectory of ALS research. Our model funds global collaboration, enables scientists to unlock insights, and allows us to conduct comprehensive ALS research.
Our one–of–a-kind efforts are enabling innovation that will lead to effective treatments, sooner rather than later.
The impact we can make, from unlocking answers about ALS to investing in drug discovery programs, has the real potential to transform the future of ALS treatments.
Will you help us make that happen? Join our community to power more of the research that's needed to make breakthroughs and save lives.
